194 related articles for article (PubMed ID: 11291579)
1. [Candida antigen and antibody kinetics during antifungal therapy in non-neutropenic intensive care patients].
Wauer HJ; West C; Tietz HJ; Kox WJ
Mycoses; 2000; 43 Suppl 2():57-61. PubMed ID: 11291579
[TBL] [Abstract][Full Text] [Related]
2. Candida infections in non-neutropenic children after the neonatal period.
Hacimustafaoglu M; Celebi S
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):923-40. PubMed ID: 21973304
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of the serum Candida antigen titer for initiation of antifungal therapy after post-remission chemotherapy in patients with acute leukemia.
Iwasaki H; Misaki H; Nakamura T; Ueda T
Int J Hematol; 2000 Apr; 71(3):266-72. PubMed ID: 10846834
[TBL] [Abstract][Full Text] [Related]
4. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
[TBL] [Abstract][Full Text] [Related]
5. [Retrospective analysis of fluconazole efficacy in Candida-colonized, non-neutropenic, surgical patients in long-term intensive care].
Kappe R; Streitzig S; Böhrer H
Dtsch Med Wochenschr; 2001 Aug; 126(33):905-8. PubMed ID: 11514925
[TBL] [Abstract][Full Text] [Related]
6. Candida endophthalmitis: focus on current and future antifungal treatment options.
Khan FA; Slain D; Khakoo RA
Pharmacotherapy; 2007 Dec; 27(12):1711-21. PubMed ID: 18041891
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis and management of Candida infection syndromes in non-neutropenic patients.
Solomkin JS
New Horiz; 1993 May; 1(2):202-13. PubMed ID: 7922404
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of the therapy of Candida esophagitis in HIV-1-infected patients with fluconazole or amphotericin B and flucytosine].
Brockmeyer NH; Hantschke D; Olbricht T; Hengge UA; Goos M
Mycoses; 1991; 34 Suppl 1():83-6. PubMed ID: 1818270
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study.
Garey KW; Neuhauser MM; Bearden DT; Cannon JP; Lewis RE; Gentry LO; Kontoyiannis DP
Mycoses; 2006 May; 49(3):226-31. PubMed ID: 16681815
[TBL] [Abstract][Full Text] [Related]
10. Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
Mariné M; Serena C; Fernández-Torres B; Pastor FJ; Guarro J
Antimicrob Agents Chemother; 2005 Nov; 49(11):4757-9. PubMed ID: 16251323
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for Candida infections in a neonatal intensive care unit in Costa Rica.
Avila-Aguero ML; Canas-Coto A; Ulloa-Gutierrez R; Caro MA; Alfaro B; Paris MM
Int J Infect Dis; 2005 Mar; 9(2):90-5. PubMed ID: 15708324
[TBL] [Abstract][Full Text] [Related]
12. Combined antifungal therapy in a murine infection by Candida glabrata.
Mariné M; Serena C; Pastor FJ; Guarro J
J Antimicrob Chemother; 2006 Dec; 58(6):1295-8. PubMed ID: 17012301
[TBL] [Abstract][Full Text] [Related]
13. A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients.
Abele-Horn M; Kopp A; Sternberg U; Ohly A; Dauber A; Russwurm W; Büchinger W; Nagengast O; Emmerling P
Infection; 1996; 24(6):426-32. PubMed ID: 9007589
[TBL] [Abstract][Full Text] [Related]
14. [Serological tests for detection of fungal infection connected with prolonged antibiotic treatment after valve replacement].
Orłowska-Baranowska E; Dabkowska M; Rawczyńska-Englert I
Pol Arch Med Wewn; 2002 Oct; 108(4):965-9. PubMed ID: 12642941
[TBL] [Abstract][Full Text] [Related]
15. Early detection of systemic candidiasis in the whole blood of patients with hematologic malignancies.
Badiee P; Kordbacheh P; Alborzi A; Zakernia M; Haddadi P
Jpn J Infect Dis; 2009 Jan; 62(1):1-5. PubMed ID: 19168950
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
17. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
Bassetti M; Ansaldi F; Nicolini L; Malfatto E; Molinari MP; Mussap M; Rebesco B; Bobbio Pallavicini F; Icardi G; Viscoli C
J Antimicrob Chemother; 2009 Sep; 64(3):625-9. PubMed ID: 19622536
[TBL] [Abstract][Full Text] [Related]
18. Candida antigen detection in two premature neonates with disseminated candidiasis.
Schreiber JR; Maynard E; Lew MA
Pediatrics; 1984 Nov; 74(5):838-41. PubMed ID: 6436783
[TBL] [Abstract][Full Text] [Related]
19. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.
Playford EG; Marriott D; Nguyen Q; Chen S; Ellis D; Slavin M; Sorrell TC
Crit Care Med; 2008 Jul; 36(7):2034-9. PubMed ID: 18552700
[TBL] [Abstract][Full Text] [Related]
20. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
Charlier C; Hart E; Lefort A; Ribaud P; Dromer F; Denning DW; Lortholary O
J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
